218 related articles for article (PubMed ID: 1242372)
1. Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats.
Breese GR; Cooper BR
Brain Res; 1975 Nov; 98(3):517-27. PubMed ID: 1242372
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Mueller RA
J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and behavioural alterations following 5,6-dihydroxytryptamine administration into brain.
Breese GR; Cooper BR; Grant LD; Smith RD
Neuropharmacology; 1974 Mar; 13(3):177-87. PubMed ID: 4407423
[No Abstract] [Full Text] [Related]
4. Genetic differences in ethanol drinking of the rat following injection of 6-OHDA, 5,6-DHT or 5,7-DHT into the cerebral ventricles.
Melchior CL; Myers RD
Pharmacol Biochem Behav; 1976 Jul; 5(1):63-72. PubMed ID: 996042
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain.
Roffler-Tarlov S; Schildkraut JJ; Draskoczy PR
Biochem Pharmacol; 1973 Nov; 22(22):2923-6. PubMed ID: 4148604
[No Abstract] [Full Text] [Related]
7. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
Erinoff L; Snodgrass SR
Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
[TBL] [Abstract][Full Text] [Related]
8. Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-OHDA), 5,6-dihydroxytryptamine (5,6-DHT) or repeated monoamine administration.
Howe JR; Yaksh TL
J Pharmacol Exp Ther; 1982 Feb; 220(2):311-21. PubMed ID: 6120226
[TBL] [Abstract][Full Text] [Related]
9. Effects of compounds structurally related to 5,6-dihydroxytryptamine on behavior and brain biogenic amines in the rat.
Donelson AC; Manian AA; Maickel RP
Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):517-20. PubMed ID: 7163644
[TBL] [Abstract][Full Text] [Related]
10. Effects of three dihydroxylated derivatives of tryptamine on the behavior and on brain amine content in mice.
Massotti M; Scotti de Carolis A; Longo VG
Pharmacol Biochem Behav; 1974; 2(6):769-76. PubMed ID: 4549398
[No Abstract] [Full Text] [Related]
11. Amphetamine-like effects of 5,6-dihydroxy tryptamine on social behaviour in the mouse.
Pöschlová N; Masek K; Krsiak M
Neuropharmacology; 1977 May; 16(5):317-21. PubMed ID: 865659
[No Abstract] [Full Text] [Related]
12. A study of the central effects of 5,6-dihydroxytryptamine.
Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
[No Abstract] [Full Text] [Related]
13. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
Shabanov PD; Bul'on VV; Lénárd L
Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
[TBL] [Abstract][Full Text] [Related]
14. Effect of modification of brain serotonin (5-HT), norepinephrine (NE) and dopamine (DA) on ethanol tolerance.
Lê AD; Khanna JM; Kalant H; LeBlanc AE
Psychopharmacology (Berl); 1981; 75(3):231-5. PubMed ID: 6798612
[TBL] [Abstract][Full Text] [Related]
15. Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopamine.
Breese GR; Smith RD; Cooper BR; Grant LD
Pharmacol Biochem Behav; 1973; 1(3):319-28. PubMed ID: 4775860
[No Abstract] [Full Text] [Related]
16. Specific effect of 5,6-dihydroxytryptamine on the monoamine fluorophore of the frog's gustatory cells.
Nada O; Hirata K
Histochemistry; 1975 Nov; 45(2):121-7. PubMed ID: 1081530
[TBL] [Abstract][Full Text] [Related]
17. Hyperphagia and increased growth in rats after intraventricular injection of 5,7-dihydroxytryptamine.
Saller CF; Stricker EM
Science; 1976 Apr; 192(4237):385-7. PubMed ID: 1257774
[TBL] [Abstract][Full Text] [Related]
18. Effects of nomifensine and desipramine on the sequelae of intracerebrally-injected 6-OHDA and 5,6-DHT.
Waddington JL
Pharmacol Biochem Behav; 1980 Dec; 13(6):915-7. PubMed ID: 7193877
[TBL] [Abstract][Full Text] [Related]
19. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
Cooper BR; Breese GR; Grant LD; Howard JL
J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
[No Abstract] [Full Text] [Related]
20. Activity, avoidance learning and regional 5-hydroxytryptamine following intra-brain stem 5,7-dihydroxytryptamine and electrolytic midbrain raphe lesions in the rat.
Lorens SA; Guldberg HC; Hole K; Köhler C; Srebro B
Brain Res; 1976 May; 108(1):97-113. PubMed ID: 1276894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
